Growth Investors Continue to Eye the Private Growth Capital Opportunity
LONDON – 4 APRIL 2022: With geopolitical tensions compounding an already volatile market backdrop, investors see turning points in private markets dynamics, as valuations adjust and investor discipline strengthens, according to new research from Numis, the independent investment bank.
Against the current backdrop of macroeconomic pressures, Numis surveyed 25 of the world’s leading growth investors, including Softbank, Andreessen Horowitz and TSG, for unique insights into the prevailing sentiment within private markets. While the survey reveals a changed environment for raising growth capital, it also highlights that global growth investors and LPs remain engaged, with plentiful capital to deploy, as they pursue attractive returns and disciplined processes.
The research revealed that growth investors are anticipating turning points in private market dynamics, especially when it comes to valuations in the coming 12 months. 70% believe the buoyant private market conditions of last year have moderated, and 95% expect valuations for private companies to adjust accordingly in the coming year. The degree to which sentiment has shifted from last year is stark, evidenced by the fact that when asked the same question in Q421, 70% of respondents expected valuations to remain intact or increase.
That said, while valuation pressure will be widespread, it will not be indiscriminate. Six in 10 growth investors expect leading companies to limit valuation pressure in the coming months.
The investors surveyed were also near unanimous on their outlook for M&A, with nine in 10 viewing it as an attractive growth strategy for portfolio companies. With softer public markets limiting exit horizons, investors anticipate a greater opportunity to target previously inaccessible companies. Numis’ recent M&A Survey also highlights incumbents’ appetite for consolidation. That survey found that 86% of FTSE 250 directors expect to undertake M&A in 2022.
Despite pressure on valuations and a constrained exit environment, Numis’ survey indicates that LPs’ appetite for private market allocations remains robust, with dry powder and scope for returns underpinning allocations. While crossover funds prioritise listed opportunities, two thirds of the growth investors surveyed said they were still expecting to make a similar number of new investments in the next 12 months as in the past year.
“Following an incredibly active 2021 – with record transaction volumes and an unparalleled number of ‘mega-rounds’ greater than $100m – private markets continue to evolve at a rapid pace. Private markets are not immune to the volatility that continues to impact public markets, and some market cooling following an exceptional year is to be expected. Nonetheless, their secular attraction and the enduring appetite of LPs’ to allocate capital to private assets will ensure the outlook remains positive. Accordingly, it comes with little surprise that growth investors expect to make a similar number of new investments in the next year as in the past 12 months.
What is clear is that investors are anticipating greater levels of scrutiny on cash burn and the reintroduction of discipline amid higher levels of uncertainty. Investor selectivity has increased amidst more careful deployment of private capital but leading companies still have the opportunity to extend their competitive advantage. We remain of the view that continued availability of private market capital at scale will encourage some companies to stay private for longer, exacerbating an already pronounced trend.”
The largest corporate broker in the UK by number of listed clients
Capital raising specialists in services including IPOs, equity issuance and block trades
Providing M&A expertise through a full suite of bespoke advice and solutions
Expert debt advice focused on robust and efficient corporate solutions
Drawing from our experience to deliver strong outcomes at IPO
Enabling the world’s most ambitious private companies to achieve their ambitions
We are the leading provider of in-depth, high quality research on UK listed companies
The largest, most experienced Sales Trading and Trading teams covering UK equities
Proactive advice combining in-depth research, distribution and execution